Correlation Between Phibro Animal and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Phibro Animal and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phibro Animal and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phibro Animal Health and Citius Oncology,, you can compare the effects of market volatilities on Phibro Animal and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phibro Animal with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phibro Animal and Citius Oncology,.
Diversification Opportunities for Phibro Animal and Citius Oncology,
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Phibro and Citius is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Phibro Animal Health and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Phibro Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phibro Animal Health are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Phibro Animal i.e., Phibro Animal and Citius Oncology, go up and down completely randomly.
Pair Corralation between Phibro Animal and Citius Oncology,
Given the investment horizon of 90 days Phibro Animal Health is expected to generate 0.21 times more return on investment than Citius Oncology,. However, Phibro Animal Health is 4.86 times less risky than Citius Oncology,. It trades about 0.1 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 1,761 in Phibro Animal Health on September 1, 2024 and sell it today you would earn a total of 576.00 from holding Phibro Animal Health or generate 32.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 61.9% |
| Values | Daily Returns |
Phibro Animal Health vs. Citius Oncology,
Performance |
| Timeline |
| Phibro Animal Health |
| Citius Oncology, |
Phibro Animal and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phibro Animal and Citius Oncology,
The main advantage of trading using opposite Phibro Animal and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phibro Animal position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Phibro Animal vs. Pacira BioSciences, | Phibro Animal vs. Dr Reddys Laboratories | Phibro Animal vs. Collegium Pharmaceutical | Phibro Animal vs. ANI Pharmaceuticals |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |